Papp, K.; Lebwohl, M.; Gottlieb, A.; Sebastian, M.; Langley, R.; Okubo, Y.; Wang, M.; Cioffi, C.; Staelens, F.; Reich, K. Bimekizumab for the Treatment of Moderate to Severe Plaque Psoriasis With Scalp, Nail and Palmoplantar Involvement Through 52 Weeks: Post-Hoc Analysis from the BE VIVID Phase 3 Trial. J of Skin 2021, 5, s18.